Vernieri, C., Caputo, R., Dieci, M. V., Vigneri, P., Giuliano, M., Curigliano, G., Toss, A., Botticelli, A., Pedersini, R., Cinieri, S., Lambertini, M., Tagliaferri, B., Rizzo, G., Sirico, M., Giordano, M., Gerratana, L., Meattini, I., Piras, M., Fabi, A., Zambelli, A. (2026). Effectiveness of first-line ET+CDK4/6i continuation beyond disease progression in a large cohort of patients with HR+/HER2− advanced breast cancer: Results from the multicenter, real-world, Italian study PALMARES-2.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1017